Fig. 2From: Nodular lymphocyte-predominant Hodgkin lymphoma characteristics, management of primary and relapsed/refractory disease and outcome analysis: the first comprehensive report from the Middle EastImpact of various factors on event free survival. a with chemotherapy + radiation therapy, surgery, radiation therapy alone and chemotherapy alone. b reason for radiation therapy (consolidation vs primary treatment vs eradication of residual disease). c various year-groups at the time of diagnosis. d rituximab in first lineBack to article page